Search

Your search keyword '"Harvey Pass"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Harvey Pass" Remove constraint Author: "Harvey Pass"
124 results on '"Harvey Pass"'

Search Results

1. Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides

2. New or enlarging hiatal hernias after thoracic surgery for early lung cancerCentral MessagePerspective

3. Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma

4. Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

5. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

6. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

7. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

8. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

9. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

10. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

11. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

12. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

13. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

14. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

15. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

16. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

17. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

18. Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer

19. Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.

20. Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.

21. Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.

22. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.

23. CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.

24. New insight into the molecular mechanisms of the biological effects of DNA minor groove binders.

25. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

26. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

27. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

28. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

29. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

30. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

31. Table S2 from A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT

32. Supplementary File S1 from A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT

33. Figure S2 from A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT

34. Supplementary Data from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

35. Data from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

36. Supplementary Figure from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

37. Data from A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT

38. Results of Two Cases of Pig-to-Human Kidney Xenotransplantation

39. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

41. Effects of Smoking, Obesity, and Pulmonary Function on Home Oxygen Use after Curative Lung Cancer Surgery

43. New or enlarging hiatal hernias after thoracic surgery for early lung cancer

44. Asbestos : Risk Assessment, Epidemiology, and Health Effects

45. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

46. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

47. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

48. Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation

49. Discussion

50. Buffy Coat Immunotranscriptomics for Diagnosis of Malignant Pleural Mesothelioma

Catalog

Books, media, physical & digital resources